Bath & Body Works, Inc. $BBWI Shares Sold by Mitsubishi UFJ Trust & Banking Corp

Mitsubishi UFJ Trust & Banking Corp trimmed its holdings in Bath & Body Works, Inc. (NYSE:BBWIFree Report) by 26.6% in the fourth quarter, HoldingsChannel.com reports. The firm owned 264,660 shares of the company’s stock after selling 95,984 shares during the quarter. Mitsubishi UFJ Trust & Banking Corp’s holdings in Bath & Body Works were worth $5,314,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in BBWI. American Century Companies Inc. boosted its holdings in Bath & Body Works by 2,204.1% in the third quarter. American Century Companies Inc. now owns 5,174,370 shares of the company’s stock valued at $133,292,000 after purchasing an additional 4,949,796 shares in the last quarter. Jupiter Asset Management Ltd. boosted its holdings in Bath & Body Works by 553.2% in the third quarter. Jupiter Asset Management Ltd. now owns 3,714,499 shares of the company’s stock valued at $95,685,000 after purchasing an additional 3,145,797 shares in the last quarter. Vaughan Nelson Investment Management L.P. acquired a new position in Bath & Body Works in the third quarter valued at approximately $43,113,000. Bank of America Corp DE boosted its holdings in shares of Bath & Body Works by 86.9% in the third quarter. Bank of America Corp DE now owns 3,399,390 shares of the company’s stock valued at $87,568,000 after acquiring an additional 1,580,176 shares during the period. Finally, Two Sigma Investments LP boosted its holdings in shares of Bath & Body Works by 1,004.1% in the third quarter. Two Sigma Investments LP now owns 1,443,312 shares of the company’s stock valued at $37,180,000 after acquiring an additional 1,312,586 shares during the period. 95.14% of the stock is owned by institutional investors and hedge funds.

Bath & Body Works Price Performance

Shares of NYSE BBWI opened at $19.20 on Monday. The stock has a fifty day moving average price of $19.89 and a 200 day moving average price of $21.10. Bath & Body Works, Inc. has a 1-year low of $14.27 and a 1-year high of $34.66. The company has a market cap of $3.87 billion, a PE ratio of 6.09, a P/E/G ratio of 1.92 and a beta of 1.43.

Bath & Body Works (NYSE:BBWIGet Free Report) last issued its quarterly earnings results on Wednesday, March 4th. The company reported $2.05 earnings per share for the quarter, topping the consensus estimate of $1.77 by $0.28. Bath & Body Works had a negative return on equity of 45.60% and a net margin of 8.90%.The firm had revenue of $2.72 billion during the quarter, compared to the consensus estimate of $2.59 billion. During the same period last year, the company earned $2.09 earnings per share. The company’s revenue for the quarter was down 2.3% on a year-over-year basis. Bath & Body Works has set its Q1 2026 guidance at 0.240-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Analysts anticipate that Bath & Body Works, Inc. will post 2.6 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 6th. Investors of record on Friday, February 20th were issued a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, February 20th. This represents a $0.80 annualized dividend and a dividend yield of 4.2%. Bath & Body Works’s dividend payout ratio (DPR) is currently 25.40%.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. Barclays increased their price objective on Bath & Body Works from $20.00 to $21.00 and gave the company an “equal weight” rating in a report on Monday, March 2nd. UBS Group increased their price objective on Bath & Body Works from $21.00 to $22.00 and gave the company a “neutral” rating in a report on Monday, February 23rd. Weiss Ratings reissued a “hold (c-)” rating on shares of Bath & Body Works in a report on Monday, April 20th. Jefferies Financial Group assumed coverage on Bath & Body Works in a report on Wednesday, January 14th. They issued a “hold” rating and a $24.00 price objective for the company. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on Bath & Body Works from $21.00 to $22.00 and gave the company a “hold” rating in a report on Tuesday, March 3rd. Three research analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the stock. According to MarketBeat, Bath & Body Works currently has a consensus rating of “Hold” and a consensus target price of $23.00.

View Our Latest Stock Analysis on BBWI

Bath & Body Works Company Profile

(Free Report)

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

See Also

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWIFree Report).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.